首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: Successful anticoagulation with fresh frozen plasma for cardiopulmonary bypass in a patient with heparin resistance: a cautionary tale
【2h】

Case Report: Successful anticoagulation with fresh frozen plasma for cardiopulmonary bypass in a patient with heparin resistance: a cautionary tale

机译:病例报告:肝素耐药性患者使用新鲜冷冻血浆成功进行抗凝治疗以进行体外循环:一个警示故事

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Heparin resistance (HR) is an increasingly common occurrence due to a greater awareness of the benefits of antithrombosis prophylaxis in hospitalised patients with low molecular weight and unfractionated heparin. Furthermore as more high-risk patients with prior heparin exposure undergo cardiac surgery we can expect to encounter more such cases. Adequate anticoagulation is essential for the safe conduct of any operation requiring cardiopulmonary bypass and is usually achieved with systemic heparinisation. We report a case of successful anticoagulation with the intraoperative administration of fresh frozen plasma in a high-risk coronary patient with HR and highlight the perils of unwitting overheparinisation in such cases. This case highlights the importance of clinical awareness of this phenomenon and the available alternative anticoagulants.
机译:由于对住院治疗的低分子量肝素和普通肝素患者更了解抗栓塞预防的益处,因此肝素抗药性(HR)越来越普遍。此外,随着更多高风险肝素暴露患者接受心脏外科手术,我们可以预期会遇到更多此类病例。对于需要进行体外循环的任何手术的安全进行而言,充分的抗凝作用是必不可少的,通常通过全身性肝素化来实现。我们报道了在高危冠心病患者中,术中新鲜冷冻血浆成功抗凝治疗的案例,并强调了在这种情况下不知不觉地肝素化过度的危险。这种情况突出了临床认识这种现象以及可用的其他抗凝剂的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号